These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Isokinetic assessment of the effects of botulinum toxin injection on spasticity and voluntary strength in patients with spastic hemiparesis. Hameau S, Bensmail D, Robertson J, Boudarham J, Roche N, Zory R. Eur J Phys Rehabil Med; 2014 Oct; 50(5):515-23. PubMed ID: 24651151 [Abstract] [Full Text] [Related]
3. Botulinum Toxin Type A Treatment Combined with Intensive Rehabilitation for Gait Poststroke: A Preliminary Study. Uchiyama Y, Koyama T, Wada Y, Katsutani M, Kodama N, Domen K. J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1975-1986. PubMed ID: 29610039 [Abstract] [Full Text] [Related]
4. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. Caty GD, Detrembleur C, Bleyenheuft C, Deltombe T, Lejeune TM. Stroke; 2008 Oct; 39(10):2803-8. PubMed ID: 18635841 [Abstract] [Full Text] [Related]
5. Combined Effects of Isokinetic Training and Botulinum Toxin Type A on Spastic Equinus Foot in Patients with Chronic Stroke: A Pilot, Single-blind, Randomized Controlled Trial. Cinone N, Letizia S, Santoro L, Facciorusso S, Armiento R, Picelli A, Ranieri M, Santamato A. Toxins (Basel); 2019 Apr 08; 11(4):. PubMed ID: 30965599 [Abstract] [Full Text] [Related]
6. Effect of botulinum toxin injection on length and lengthening velocity of rectus femoris during gait in hemiparetic patients. Lampire N, Roche N, Carne P, Cheze L, Pradon D. Clin Biomech (Bristol); 2013 Feb 08; 28(2):164-70. PubMed ID: 23332578 [Abstract] [Full Text] [Related]
7. Effect of rehabilitation and botulinum toxin injection on gait in chronic stroke patients: a randomized controlled study. Roche N, Zory R, Sauthier A, Bonnyaud C, Pradon D, Bensmail D. J Rehabil Med; 2015 Jan 08; 47(1):31-7. PubMed ID: 25268656 [Abstract] [Full Text] [Related]
8. Meaningful improvement in walking performance after Botulinum neurotoxin A (BoNT-A) in chronic spastic patients. Cioncoloni D, Taddei S, Bielli S, Annunziata P, Mazzocchio R. NeuroRehabilitation; 2014 Jan 08; 34(1):185-92. PubMed ID: 24284465 [Abstract] [Full Text] [Related]
15. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke. Santamato A, Cinone N, Panza F, Letizia S, Santoro L, Lozupone M, Daniele A, Picelli A, Baricich A, Intiso D, Ranieri M. Drugs; 2019 Feb 08; 79(2):143-160. PubMed ID: 30623347 [Abstract] [Full Text] [Related]
16. Contributions to the understanding of gait control. Simonsen EB. Dan Med J; 2014 Apr 08; 61(4):B4823. PubMed ID: 24814597 [Abstract] [Full Text] [Related]